Drug recall · July 29, 2020
Famotidine Injection recall
Why: TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acquisition Co, LLC, Mukilteo, WA 98275, NDC 63323-739-12
- Lots / codes
Lot #: 6122639, Exp. Date 08/2021
- Quantity
- N/A
- Company
- HF Acquisition Co. LLC, Mukilteo, WA
- Distribution
- The vials were distributed to one consignee located in CT.
- Initiated
- June 17, 2020 · Voluntary: Firm initiated
- Classified
- July 21, 2020
- Reported
- July 29, 2020
- Ended
- April 13, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Famotidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.